Akari Therapeutics Plc Interest Expense Nonoperating
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- Akari Therapeutics Plc interest expense nonoperating for the quarter ending 2026-06-30 was $80.00K, a 60.00% increase year-over-year.
- Akari Therapeutics Plc interest expense nonoperating for the quarter ending 2026-03-31 was $61.00K, a 10.91% increase year-over-year.
- Akari Therapeutics Plc interest expense nonoperating for the quarter ending 2025-12-31 was $723.00K, a 483.06% increase year-over-year.
- Akari Therapeutics Plc interest expense nonoperating for the quarter ending 2025-09-30 was $121.00K, a 75.36% increase year-over-year.
- Akari Therapeutics Plc interest expense nonoperating for fiscal 2025 was $949.00K, a 288.93% increase from fiscal 2024.
- Akari Therapeutics Plc interest expense nonoperating for fiscal 2024 was $244.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $80.00K 10-Q · filed 2026-08-13 | $141.00K 10-Q · filed 2026-08-13 | $864.00K derived: sum of 3 quarters · filed 2026-08-13 | $985.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $61.00K 10-Q · filed 2026-05-19 | $784.00K derived: sum of 2 quarters · filed 2026-05-19 | $905.00K derived: sum of 3 quarters · filed 2026-05-19 | $955.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $723.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $844.00K derived: sum of 2 quarters · filed 2026-03-30 | $894.00K derived: sum of 3 quarters · filed 2026-08-13 | $949.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $121.00K 10-Q · filed 2025-11-13 | $171.00K derived: sum of 2 quarters · filed 2026-08-13 | $226.00K 10-Q · filed 2025-11-13 | $350.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $50.00K 10-Q · filed 2026-08-13 | $105.00K 10-Q · filed 2026-08-13 | $229.00K derived: sum of 3 quarters · filed 2026-08-13 | $298.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $55.00K 10-Q · filed 2026-05-19 | $179.00K derived: sum of 2 quarters · filed 2026-05-19 | $248.00K derived: sum of 3 quarters · filed 2026-05-19 | $299.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $193.00K derived: sum of 2 quarters · filed 2026-03-30 | $244.00K derived: sum of 3 quarters · filed 2026-03-30 | $244.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $69.00K 10-Q · filed 2025-11-13 | $120.00K derived: sum of 2 quarters · filed 2025-11-13 | $120.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $51.00K 10-Q · filed 2025-08-13 | $51.00K 10-Q · filed 2025-08-13 |